CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • The Right Perspective Makes the Impossible Possible

    Stage 4 lung cancer patient Bob Carlson shares his cancer immunotherapy story.

    April 2, 2015| CRI Staff
  • Pam G

    Pam G’s Immunotherapy Story

    Lung Cancer | Diagnosed 2013 I would not be alive today if it were not for this…
    March 17, 2015| CRI Staff
  • What Cancer Patients Need to Know About the Opdivo Approval

    Now that Opdivo (nivolumab) has been FDA approved for two cancer types, many patients are wondering: what’s…

    March 13, 2015| Emily Helck
  • Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer

    The results of a phase III trial are clear: the PD-1 checkpoint inhibitor nivolumab improves survival for…

    January 13, 2015| Matthew Tontonoz
  • Smoke Screens: Searching for the Causes of Lung Cancer

    On the 50th anniversary of the Surgeon General’s report, a look back at the science and politics…

    January 31, 2014| Matthew Tontonoz
Previous Page
1 2 3 4

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute